Understanding the economics of COVID-19 vaccination in Africa

Africa’s existing vaccine market, estimated at $1.3 billion, is expected to reach a value of up to $2.35 billion by 2030, supported by population growth, expanded vaccination and new products being required. Nonetheless, the African Vaccine Manufacturing Initiative estimates that the continent can currently produce less than one per cent of its vaccine needs. JP Fabri, Founding Partner, Seed Consultancy joins CNBC Africa for more.

Wed, 23 Jun 2021 10:07:48 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.